| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Diclofenac | FAERS: 2 | US FAERS | |
| 2 | Mesalamine | FAERS: 2 | US FAERS | |
| 3 | Arthrotec | FAERS: 1 | US FAERS | |
| 4 | Bortezomib | FAERS: 1 | OFFSIDES US FAERS | |
| 5 | Bosentan | FAERS: 1 | US FAERS | |
| 6 | Carbamazepine | FAERS: 1 | US FAERS | |
| 7 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 8 | Minocycline | FAERS: 1 | US FAERS | |
| 9 | Phenytoin | FAERS: 1 | US FAERS | |
| 10 | gadodiamide | FAERS: 1 | US FAERS | |
| 11 | Cytarabine | OFFSIDES | ||
| 12 | Daunorubicin | OFFSIDES | ||
| 13 | Mercaptopurine | OFFSIDES | ||
| 14 | Sirolimus | OFFSIDES | ||
| 15 | isoniazid, pyrazinamide, rifampin drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.